Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsNGM Biopharmaceuticals, Inc. announced it has initiated a Phase I/Ib clinical study of NGM438 for the treatment of patients with advanced solid tumors.
[NGM Biopharmaceuticals, Inc.]
Home Newsletters Immune Regulation News NGM Bio Announces Initiation of Phase 1/1b Clinical Study of NGM438 for...
